Home | About FPMPAM | FPMPAM Committee | From The President | In The News | Events | Outreach Programmes | Newsletter | Affiliates
2014 Federation of Private Medical Practitioners’ Associations, Malaysia
The Federation of Private Medical Practitioners Associations of Malaysia (FPMPAM) has received several reports alleging that some private hospitals, MCOs and third party payers may have policies or directives that contravene the Code of Professional Conduct (Code) of the Malaysian Medical Council (MMC).
As in a recent case, a doctor was sacked by the Management of a private hospital when he reported the wrongdoings of the hospital to the MMC. The said doctor then sued the hospital for wrongful termination. The court subsequently found the hospital had acted wrongfully in the said case.
The Private Health Care Facilities and Services Act (PHFSA) require all private healthcare facilities board of management to comply with the requirements of the MMC’s Code. The provisions in the PHFSA include, among others:
(a) a change in the powers of the registered medical practitioner or dental practitioner over the medical or dental management of patients as vested in paragraph 78(a)… (d) the contravention of the code of ethics of any professional regulatory body of the medical, dental, nursing or midwifery profession …” |
Similarly, all doctors practising in private hospitals and other private healthcare facilities are required to comply with the MMC’s Code, its guideline Duties of a Doctor, comprising Good Medical Practice and Confidentiality, and the MMC’s other guidelines.
Section 2.2.2 of the MMC’s Code states “A practitioner may not improperly disclose information which he obtained in confidence from or about a patient.”
Section 3.2 of Good Medical Practice states “In the final analysis, good medical practice dictates that the doctor must exert all in his powers to preserve patient confidentiality. The information that the doctor has come to possess is, in the first place, through the patient's voluntary revelations and consent to submit to physical examination and diagnostic investigative procedures. It is the patient's belief that such information will be kept private and used solely for his benefit.”
The duty of confidence is enunciated in detail in the MMC’s document Confidentiality. The doctor still has an obligation to keep personal information confidential after a patient dies.
The FPMPAM calls on all parties to always ensure that patients’ rights and interests are paramount and desist from policies and/or directives that contravene the MMC’s Code.
The FPMPAM will support all necessary action by doctors who refuse to enter into such contracts that may result in them breaching the law. This will include seeking legal recourse to support doctors who have been victimised because they have refused such contracts.
We urge that all such contracts be forwarded to the Medical Practice Division, Ministry of Health for vetting and for record as required by PHFSA.
###
For further information or media enquiries, please contact:
Dr. SC Ng
Medical Affairs Committee.
FPMPAM
Email: acadmed@po.jaring.my
Tel: 603-4023 4700
5th FPMPAM ASC
Details >>
FPMPAM / AMAM Joint ASM 2023
Details >>
JA Assure Partners FPMPAM To Offer Professional Indemnity Insurance Platform To All Medical Professionals Of FPMPAM
Details >>
Covid Fight: Private docs played key role
Details >>
BIOLOGIC ADVISORY GROUP MY: Consensus Guidelines in Usage of Biologics in Dermatology during Covid-19 Pandemic
Details >>
MOH Circular - Quarantine Process for General Practitioners
Details >>
Handbook of 2019-nCoV Pneumonia Control and Prevention
Details >>
Edaran Kemaskini Guidelines on 2019 Novel Coronavirus Management in Malaysia
Details >>
Implementation of Data Breach Notification
Details >>
Guidelines on Continuing Professional Development (CPD) for Medical Practitioners In Malaysia
Download >>
Specialist Medical Practitioners Continuing Professional Development (CPD) Policies and Guidelines
Read >>
Specialist Medical Practitioners Continuing Professional Development (CPD) Policies and Guidelines
Read >>
Joint Integrated Healthcare Committee (JIHC) Term Sheet
Click here >>
Joint Integrated Healthcare Committee (JIHC) Terms of Reference
Click here >>
National Pharmaceutical Regulatory Agency
Click here >>
NPRA: Reporting medicinal problems
Click here >>
Makluman Kontraindikasi Penggunaan Ubat Yang Mengandungi Codeine Untuk Kanak-Kanak Beumur Bawah 12 Tahun Dan Ibu Yang Menyusu Susulan Risiko Respiratory Depression
Click here >>
Peringatan: Langkah-Langkah Pengurangan Risiko Bagi Kesan Advers Kulit Tang Serius Susulan Penggunaan Allopurinol
Click here >>
VALPROATE
Guide for HCP >>
Patient Information >>
Sodium Valproate (Guide for HCP) >>
NDST Report 2011
Click here >>
Garis Panduan Pemantauan Keselamatan Produk ESAs dan Pelaporan Kesan Advers PRCA
Click here >>
Report On Suspected Adverse Drug Reactions
Click here >>
MADRAC Newsletter Vol 26 Issue 2 / 2018
Read >>
MADRAC KE 146 - Traditional Medicine found Adulterated
Read >>
BPFK website: Cancellation of Registered Traditional Products / Notified Cosmetics
Read >>
Pharmacy Services Division: List of Adulterated Products
Read >>
Pharmacy Services Division: Press Releases
Read >>